AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ARBUTHNOT BANKING GROUP PLC

Regulatory Filings Aug 12, 2024

7492_rns_2024-08-12_1cfcaa8b-3fd3-4974-87c6-b7cbbc926d88.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0689A

Arbuthnot Banking Group PLC

12 August 2024

12 August 2024

Arbuthnot Banking Group PLC

Change of registered office

Arbuthnot Banking Group PLC ("the Company") announces in accordance with AIM Rule 17, the change of its registered office from:

Arbuthnot House, 7 Wilson Street, London EC2M 2SN

to Arbuthnot House, 20 Finsbury Circus, London EC2M 7EA. 

This change took effect on 12 August 2024.

The Directors of the Company accept responsibility for the contents of this announcement.

Enquiries:

Arbuthnot Banking Group                                                                                                           020 7012 2400

Sir Henry Angest, Chairman and Chief Executive

Andrew Salmon, Group Chief Operating Officer

James Cobb, Group Finance Director

Grant Thornton UK LLP (Nominated Adviser and

AQSE Exchange Corporate Adviser)                                                                                         020 7383 5100

Colin Aaronson / Samantha Harrison / Ciara Donnelly 

Shore Capital (Broker)                                                                                                                   020 7408 4090

Daniel Bush / David Coaten / Tom Knibbs

H / Advisors Maitland (Financial PR)                                                                                     020 7379 5151

Sam Cartwright

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CROFIFEDTDIFLIS

Talk to a Data Expert

Have a question? We'll get back to you promptly.